Advancis Pharmaceutical

Advancis Pharmaceutical Corp., Focused on Developing and Commercializing Novel Anti-Infective Products, Leverages Pulsed Dosing Technology to Address Antibiotic Resistance. Pulsed dosing technology enables repeated administration of anti-infective drugs, including existing medications and NCEs. This approach has the potential to reduce total dosage, shorten treatment duration, minimize side effects, and enhance patient compliance.